Role of Bioimpedance Vectorial Analysis in Cardio-Renal Syndromes

Seminars in Nephrology

Volumn 32, Issue 1, 2012, Pages 93-99

  Aspromonte, Nadia ^a   Cruz, Dinna N ^b,c   Ronco, Claudio ^b,c   Valle, Roberto ^d  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c International Renal Research Institute   (Italy)

^d Ospedale Civile   (Italy)

Author keywords

Acute heart failure; Bioimpedance vectorial analysis; Cardio renal syndromes; Chronic kidney disease

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; LOOP DIURETIC AGENT;

ACUTE HEART FAILURE; ARTICLE; BIOELECTRICAL IMPEDANCE; BODY FLUID; CARDIORENAL SYNDROME; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; FLUID RETENTION; GLOMERULUS FILTRATION RATE; HEART HEMODYNAMICS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; IMPEDANCE; ISCHEMIC HEART DISEASE; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ACUTE DISEASE; BIOLOGICAL MARKERS; BLOOD VOLUME; BODY COMPOSITION; CARDIO-RENAL SYNDROME; DIELECTRIC SPECTROSCOPY; ELECTRIC IMPEDANCE; HEART FAILURE; HEMOFILTRATION; HUMANS; NATRIURETIC PEPTIDE, BRAIN; RENAL INSUFFICIENCY, CHRONIC; WATER-ELECTROLYTE IMBALANCE;

EID: 84857382442     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2011.11.012     Document Type: Article

References (41)

1. Ronco C., McCullough P., Anker S.D., Anand I., Aspromonte N., Bagshaw S.M., et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2010, 31:703-711.
2. Cruz D.N., Bagshaw S.M. Heart-kidney interaction: epidemiology of cardio-renal syndromes. Int J Nephrol 2010, 2011:351291.
3. Ronco C., Cruz D.N., Ronco F. Cardio-Renal syndromes. Curr Opin Crit Care 2009, 15:384-391.
4. Yancy C.W., Lopatin M., Stevenson L.W., De Marco T., Fonarow G.C. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol 2006, 47:76-84. ADHERE Scientific Advisory Committee and Investigators.
5. Bagshaw S.M., Cruz D.N., Aspromonte N., Daliento L., Ronco F., Sheinfeld G., et al. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant 2010, 25:1406-1416.
6. Cowie M.R., Komajda M. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective study in heart failure (POSH). Eur Heart J 2006, 27:1216-1222.
7. Forman D.E., Butler J., Wang Y., Abraham W.T., O'Connor C.M., Gottlieb S.S., et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004, 43:61-67.
8. Nohria A., Hasselblad V., Stebbins A., Pauly D.F., Fonarow G.C., Shah M., et al. Cardio-Renal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 2008, 51:1268-1274.
9. Androne A.S., Hryniewicz K., Hudaihed A., et al. Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 2004, 93:1254-1259.
10. Gheorghiade M., Follath F., Ponikowski P., Barsuk J.H., Blair J.E., Cleland J.G., et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 2010, 12:423-433. European Society of Cardiology; European Society of Intensive Care Medicine.
11. Iwanaga Y., Nishi I., Furuichi S., et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006, 47:742-748.
12. Maisel A., Mueller C., Adams K., et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008, 10:824-839.
13. Damman K., van Deursen V.M., Navis G., Voors A.A., van Veldhuisen D.J., Hillege H.L. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009, 53:5828.
14. Drazner M.H., Rame J.E., Stevenson L.W., Dries D.L. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001, 345:574-581.
15. Sergy G., Bussolotto M., Perini P., et al. Accuracy of bioelectrical impedance analysis in estimation of extracellular space in healthy subjects and in fluid retention states. Ann Nutr Metab 1994, 38:158-165.
16. Valle R., Aspromonte A. Use of brain natriuretic peptide and bioimpedance to guide therapy in heart failure patients. Contrib Nephrol 2010, 164:209-216. In: Ronco C, Costanzo MR, Maisel AS, editors. Fluid overload: diagnosis and management.
17. Piccoli A. Bioelectric impedance measurement for fluid status assessment. Contrib Nephrol 2010, 164:143-152.
18. Parrinello G., Paterna S., Di Pasquale P., Torres D., Fatta A., Mezzero M., et al. The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. J Card Fail 2008, 14:676-686.
19. Söderberg M., Hahn R.G., Cederholm T. Bioelectric impedance analysis of acute body water changes in congestive heart failure. Scand J Clin Lab Invest 2001, 61:89-94.
20. Aspromonte N., Giovinazzo P., Milani L., Valle R. Randomized comparison of the effects of treatment of refractory heart failure (HF) guided by plasma B-type natriuretic peptide (BNP) concentrations versus empirical therapy in hospitalized patients. Eur J Heart Fail Suppl 2005, 4:637.
21. Paterna S., Di Pasquale P., Parrinello G., et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol 2005, 45:1997-2003.
22. Faggiano P., Valle R., Aspromonte N., D'Aloia A., Di Tano G., Barro S., et al. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure?. Role of serial measurements to improve short-term prognostic stratification. Int J Cardiol 2010, 140:88-94.
23. Valle R., Aspromonte N., Giovinazzo P., Carbonieri E., Chiatto M., di Tano G., et al. B-type natriuretic peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure. J Card Fail 2008, 14:219-224.
24. Aspromonte N., Cruz D.N., Valle R., Bonello M., Tubaro M., Gambaro G., et al. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure. Expert Opin Drug Metab Toxicol 2011, 7:1049-1063.
25. Valle R., Aspromonte N., Milani L., Peacock F.W., Maisel A.S., Santini M., et al. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. Heart Fail Rev 2011, 16:519-529.
26. Lins R.L., Elseviers M., Rogiers P., Van Hoeyweghen R.J., De Raedt H., Zachee P., et al. Importance of volume factors in dialysis related hypertension. Clin Nephrol 1997, 48:29-33.
27. Ozkahya M., Toz H., Unsal A., Ozerkan F., Asci G., Gurgun C., et al. Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis 1999, 34:218-221.
28. Gunal A.I., Duman S., Ozkahya M., Toz H., Asci G., Akcicek F., et al. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 2001, 37:588-593.
29. Jaeger J.Q., Mehta R.L. Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 1999, 10:392-403.
30. Kouw P.M., Olthof C.G., ter Wee P.M., Oe L.P., Donker A.J., Schneider H., et al. Assessment of post-dialysis dry weight: an application of the conductivity measurement method. Kidney Int 1992, 41:440-444.
31. Chen Y.C., Chen H.H., Yeh J.C., Chen S.Y. Adjusting dry weight by extracellular volume and body composition in hemodialysis patients. Nephron 2002, 92:91-96.
32. Chamney P.W., Kramer M., Rode C., Kleinekofort W., Wizemann V. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int 2002, 61:2250-2258.
33. Scharfetter H., Wirnsberger G.H., Holzer H., Hutten H. Influence of ionic shifts during dialysis on volume estimations with multifrequency impedance analysis. Med Biol Eng Comput 1997, 35:96-102.
34. Moissl U.M., Wabel P., Chamney P.W., Bosaeus I., Levin N.W., Bosy-Westphal A., et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas 2006, 27:921-933.
35. Basile C., Vernaglione L., Di Iorio B., Bellizzi V., Chimienti D., Lomonte C., et al. Development and validation of bioimpedance analysis prediction equations for dry weight in hemodialysis patients. Clin J Am Soc Nephrol 2007, 2:675-680.
36. Shulman T., Heidenheim A.P., Kianfar C., Shulman S.M., Lindsay R.M. Preserving central blood volume: changes in body fluid compartments during hemodialysis. ASAIO J 2001, 47:615-618.
37. Zhu F., Kuhlmann M.K., Sarkar S., Kaitwatcharachai C., Khilnani R., Leonard E.F., et al. Adjustment of dry weight in hemodialysis patients using intradialytic continuous multifrequency bioimpedance of the calf. Int J Artif Organs 2004, 27:104-109.
38. Piccoli A., Pillon L., Dumler F. Impedance vector distribution by sex, race, body mass index, and age in the United States: standard reference intervals as bivariate Z scores. Nutrition 2002, 18:153-167.
39. Piccoli A. Identification of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis. The Italian Hemodialysis-Bioelectrical Impedance Analysis (HD-BIA) study group. Kidney Int 1998, 53:1036-1043.
40. Piccoli A., Pillon L., Favaro E. Asymmetry of the total body water prediction bias using the impedance index. Nutrition 1997, 13:438-441.
41. Jebb S.A., Cole T.J., Doman D., Murgatroyd P.R., Prentice A.M. Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br J Nutr 2000, 83:115-122.